| Author | dc.contributor.author | Reck, M. | |
| Author | dc.contributor.author | Socinski, M. A. | |
| Author | dc.contributor.author | Cappuzzo, F. | |
| Author | dc.contributor.author | Orlandi, F. | |
| Author | dc.contributor.author | Stroyakovskiy, D. | |
| Author | dc.contributor.author | Nogami, N. | |
| Author | dc.contributor.author | Rodriguez-Abreu, D. | |
| Author | dc.contributor.author | Moro-Sibilot, D. | |
| Author | dc.contributor.author | Thomas, C. A. | |
| Author | dc.contributor.author | Barlesi, F. | |
| Admission date | dc.date.accessioned | 2018-11-09T14:20:42Z | |
| Available date | dc.date.available | 2018-11-09T14:20:42Z | |
| Publication date | dc.date.issued | 2018-04 | |
| Cita de ítem | dc.identifier.citation | Journal of Thoracic Oncology Volumen: 13 Número: 4 Páginas: S77-S78 Suplemento: S Abstract de reunión: 134PD | es_ES |
| Identifier | dc.identifier.other | 10.1016/S1556-0864(18)30409-X | |
| Identifier | dc.identifier.uri | https://repositorio.uchile.cl/handle/2250/152544 | |
| Patrocinador | dc.description.sponsorship | F. Hoffmann-La Roche Ltd/Genentech, Inc | es_ES |
| Lenguage | dc.language.iso | en | es_ES |
| Publisher | dc.publisher | Elsevier | es_ES |
| Source | dc.source | Journal of Thoracic Oncology | es_ES |
| Título | dc.title | Primary PFS and safety analyses of a randomized phase III study of carboplatin plus paclitaxel plus /- bevacizumab, with or without atezolizumab in 1L nonsquamous metastatic NSCLC (IMpower150) | es_ES |
| Document type | dc.type | Artículo de revista | |
| dcterms.accessRights | dcterms.accessRights | Acceso a solo metadatos | es_ES |
| Cataloguer | uchile.catalogador | rgf | es_ES |
| Indexation | uchile.index | Artículo de publicación ISI | es_ES |
